GTF3C5

General transcription factor 3C polypeptide 5 · Q9Y5Q8 · GTF3C5 on Sugi Atlas →

0 patent compounds predicted against GTF3C5, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to GTF3C5 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma PHASE3UNKNOWN
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room PHASE2/PHASE3COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection nanUNKNOWN
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism nanUNKNOWN
A Study of the Genetic Analysis of Brain Disorders nanCOMPLETED
Genetic Studies of Inflammatory Bowel Disease nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Diet, Genetics, and CVD Risk Factor Response in Blacks nanCOMPLETED
Recombinant Interferon Alfa-2b in Treating Patients With Melanoma nanCOMPLETED
Risk Factors for the Development of Celiac Disease in Genetically Predisposed Children nanUNKNOWN
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma nanWITHDRAWN
Pheno- & Genotyping POF (WHO III) nanUNKNOWN
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B) nanCOMPLETED
Family Resilience Initiative Research Program nanUNKNOWN
Identification of Viable Human Embryos Using Three Different Methods nanCOMPLETED
Nasturtium (Tropaeolum Majus L) Intake and Biochemical Parameters in Pre-diabetic Subjects in Bogota Colombia nanCOMPLETED
Genetic Variants Associated With Adolescent Suicide Attempts nanCOMPLETED
Familial Intracranial Aneurysm Study II nanCOMPLETED
Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone. nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Gut Microbiome in Patients With Polycystic Ovary Syndrome nanUNKNOWN
Caffeine, Genetic Variation and Athletic Performance nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a GTF3C5 binder may also engage these)

ProteinNameSimilarity
Q8R2T8 1.000 Q8R2T8 →
Q9NVU0 0.979 Q9NVU0 →
Q9CZT4 0.976 Q9CZT4 →
Q921C3 0.972 Q921C3 →
Q69Z66 0.971 Q69Z66 →
Q80UV9 0.971 Q80UV9 →
O15259 0.970 O15259 →
Q5U2X1 0.969 Q5U2X1 →
Q3ZBT2 0.969 Q3ZBT2 →
Q9H8E8 0.969 Q9H8E8 →
Q5R6Y9 0.969 Q5R6Y9 →
F1R7R1 0.969 F1R7R1 →
Q5VUG0 0.968 Q5VUG0 →
Q3B7T1 0.968 Q3B7T1 →
Q5M954 0.968 Q5M954 →
Q8CID0 0.968 Q8CID0 →
Q8K2L8 0.968 Q8K2L8 →
TAF1L Transcription initiation factor TFIID subunit 1-like 0.968 landscape →
Q8VDD9 0.968 Q8VDD9 →
Q6DC03 0.968 Q6DC03 →
Q5PQS6 0.968 Q5PQS6 →
Q9UK97 0.968 Q9UK97 →
SETDB1 Histone-lysine N-methyltransferase SETDB1 0.967 landscape →
Q91WR3 0.967 Q91WR3 →
F4HRV8 0.967 F4HRV8 →
Q9XT62 0.967 Q9XT62 →
Q8N5Y2 0.967 Q8N5Y2 →
Q60544 0.967 Q60544 →
Q9QXN3 0.967 Q9QXN3 →
Q7TPQ3 0.967 Q7TPQ3 →